{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:30:04Z","timestamp":1793194204770,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.nano.2022.102536","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T04:08:33Z","timestamp":1645502913000},"page":"102536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections"],"prefix":"10.1016","volume":"42","author":[{"given":"Chelsea R.","family":"Thorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zlatko","family":"Kopecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Wignall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Kral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive A.","family":"Prestidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2022.102536_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/microorganisms5020015","article-title":"Approaches to dispersing medical biofilms","volume":"5","author":"Fleming","year":"2017","journal-title":"Microorganisms"},{"key":"10.1016\/j.nano.2022.102536_bb0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2014.10.024","article-title":"ESCMID guideline for the diagnosis and treatment of biofilm infections 2014","volume":"21","author":"Hoiby","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.nano.2022.102536_bb0015","series-title":"World Health Organisation: Geneva","author":"WHO","year":"2017"},{"issue":"8","key":"10.1016\/j.nano.2022.102536_bb0020","first-page":"1811","article-title":"Aminoglycosides: a practical review","volume":"58","author":"Gonzalez","year":"1998","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.nano.2022.102536_bb0025","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","article-title":"The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin","volume":"15","author":"Tseng","year":"2013","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.nano.2022.102536_bb0030","first-page":"1","article-title":"Nano-fats for bugs: the benefits of lipid nanoparticles for antimicrobial therapy","author":"Thorn","year":"2021","journal-title":"Drug Deliv Transl Res"},{"issue":"24","key":"10.1016\/j.nano.2022.102536_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202100531","article-title":"Tobramycin liquid crystal nanoparticles eradicate cystic fibrosis-related Pseudomonas aeruginosa biofilms","volume":"7","author":"Thorn","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.nano.2022.102536_bb0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jconrel.2014.03.055","article-title":"Lipid and polymer nanoparticles for drug delivery to bacterial biofilms","volume":"190","author":"Forier","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2022.102536_bb0045","series-title":"Controlled release from cubic liquid-crystalline particles (cubosomes)","first-page":"21","volume":"Vol. 127","author":"Boyd","year":"2005"},{"issue":"19","key":"10.1016\/j.nano.2022.102536_bb0050","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1021\/la010161w","article-title":"Novel process for producing cubic liquid crystalline nanoparticles (cubosomes)","volume":"17","author":"Spicer","year":"2001","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.nano.2022.102536_bb0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejpb.2010.12.034","article-title":"Preparation of phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines","volume":"79","author":"Rizwan","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2022.102536_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2019.12.037","article-title":"Bacterial lipase triggers the release of antibiotics from digestible liquid crystal nanoparticles","volume":"319","author":"Thorn","year":"2020","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.nano.2022.102536_bb0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1021\/acsabm.8b00062","article-title":"Pseudomonas infection responsive liquid crystals for glycoside hydrolase and antibiotic combination","volume":"1","author":"Thorn","year":"2018","journal-title":"ACS Appl Bio Mater"},{"issue":"8","key":"10.1016\/j.nano.2022.102536_bb0070","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1021\/acsinfecdis.1c00014","article-title":"Protective liquid crystal nanoparticles for targeted delivery of PslG \u2014 a biofilm dispersing enzyme","volume":"7","author":"Thorn","year":"2021","journal-title":"ACS Infect Dis"},{"issue":"2","key":"10.1016\/j.nano.2022.102536_bb0075","first-page":"157","article-title":"Colistin: an antibiotic and its role in multiresistant gram-negative infections","volume":"47","author":"Loho","year":"2015","journal-title":"Acta Med Indones"},{"issue":"5","key":"10.1016\/j.nano.2022.102536_bb0080","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-019-01095-z","article-title":"Amikacin liposome inhalation suspension: a review in Mycobacterium avium complex lung disease","volume":"79","author":"Shirley","year":"2019","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.nano.2022.102536_bb0085","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0005-2736(99)00217-5","article-title":"Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells","volume":"1463","author":"Sachetelli","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"10.1016\/j.nano.2022.102536_bb0090","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"17","key":"10.1016\/j.nano.2022.102536_bb0095","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2174\/1568026617666170105144830","article-title":"Antimicrobial peptides for the control of biofilm formation","volume":"17","author":"Moreno","year":"2017","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nano.2022.102536_bb0100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2018.11.009","article-title":"Cubosomes for topical delivery of the antimicrobial peptide LL-37","volume":"134","author":"Boge","year":"2019","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2022.102536_bb0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcis.2018.03.062","article-title":"Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide","volume":"522","author":"Boge","year":"2018","journal-title":"J Colloid Interface Sci"},{"issue":"17","key":"10.1016\/j.nano.2022.102536_bb0110","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.1021\/acs.langmuir.6b00338","article-title":"Lipid-based liquid crystals as carriers for antimicrobial peptides: phase behavior and antimicrobial effect","volume":"32","author":"Boge","year":"2016","journal-title":"Langmuir"},{"issue":"9","key":"10.1016\/j.nano.2022.102536_bb0115","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1128\/AAC.00154-10","article-title":"Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo","volume":"54","author":"Uccelletti","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"1\u20132","key":"10.1016\/j.nano.2022.102536_bb0120","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2008.08.022","article-title":"Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs","volume":"365","author":"Lee","year":"2009","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.nano.2022.102536_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jconrel.2011.03.033","article-title":"Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration","volume":"153","author":"Nguyen","year":"2011","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2022.102536_bb0130","doi-asserted-by":"crossref","first-page":"4209","DOI":"10.2147\/DDDT.S86370","article-title":"Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin","volume":"9","author":"Peng","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"174","key":"10.1016\/j.nano.2022.102536_bb0135","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fcimb.2019.00174","article-title":"Characterization of the in vitro, ex vivo, and in vivo efficacy of the antimicrobial peptide DPK-060 used for topical treatment","volume":"9","author":"Hakansson","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.nano.2022.102536_bb0140","series-title":"How to overcome the antibiotic crisis : facts, challenges, technologies and future perspectives","first-page":"475","article-title":"Anti-infectives in drug delivery\u2014overcoming the gram-negative bacterial cell envelope","author":"Graef","year":"2016"},{"issue":"14","key":"10.1016\/j.nano.2022.102536_bb0145","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1080\/10826079808006616","article-title":"Development and validation of a stability-indicating HPLC method for the determination of tobramycin and its related substances in an ophthalmic suspension","volume":"21","author":"Russ","year":"2006","journal-title":"J Liq Chromatogr Relat Technol"},{"issue":"4","key":"10.1016\/j.nano.2022.102536_bb0150","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.chom.2013.03.003","article-title":"Pseudomonas aeruginosa disrupts Caenorhabditis elegans iron homeostasis, causing a hypoxic response and death","volume":"13","author":"Kirienko","year":"2013","journal-title":"Cell Host Microbe"},{"issue":"280","key":"10.1016\/j.nano.2022.102536_bb0155","first-page":"280","article-title":"Deferiprone and gallium-protoporphyrin have the capacity to potentiate the activity of antibiotics in Staphylococcus aureus small colony variants","volume":"7","author":"Richter","year":"2017","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.nano.2022.102536_bb0160","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/wrr.12074","article-title":"Development of a novel ex vivo porcine skin explant model for the assessment of mature bacterial biofilms","volume":"21","author":"Yang","year":"2013","journal-title":"Wound Repair Regen"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963422000223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T07:18:22Z","timestamp":1761549502000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963422000223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":32,"alternative-id":["S1549963422000223"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2022.102536","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid crystal nanoparticle platform for increased efficacy of cationic antimicrobials against biofilm infections","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2022.102536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102536"}}